On July 19, Incyte announced that the FDA approved ruxolitinib cream 1.5% for the topical treatment of non-segmental vitiligo in adults and children over 12
SAN DIEGO–(BUSINESS WIRE)–Jul. 18, 2022– Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a New Drug Application (NDA) to the U.S.
Inflammatory myofibroblastic tumor (IMT), also known as plasma cell granuloma, inflammatory pseudotumor, fibrous histiocytoma, fibrous xanthoma, and xanthogranuloma, is a tumor composed of smooth muscle
On July 18, FiercePharma released the 2021 TOP10 list of global generic drug giants. The global sales of generic drugs in 2021 is unknown, but
With the rapid growth of bioinformatics knowledge related to peptides and proteins, peptide-based drug design strategies have become increasingly active recently. In the past, peptide-based
Endo Moving Toward Bankruptcy Filing Without Opioid Settlement Deal WSJ Endo is considering filing for bankruptcy protection to get rid of a massive $8 billion
Exelixis Announces Cabozantinib in Combination with Nivolumab and Ipilimumab Significantly Improved Progression-Free Survival in Phase 3 COSMIC-313 Pivotal Trial in Patients with Previously Untreated Advanced
On July 13, Merck and Orion announced that they have reached a cooperation agreement to jointly develop and commercialize Orion’s drug ODM-208 and other drugs
DNA is colorless, so if we want to see it, we need to use staining techniques. Since the maturity of PCR technology, DNA staining methods
Since the launch of the first CAR-T cell therapy in 2017, the era of cell therapy has officially begun, and good clinical results have been
To talk about the disadvantages of random coupling, there are two main points. First, random coupling mainly relies on natural amino acids, and the coupling
On July 12, WHO Director-General Tedros Adhanom Ghebreyesus stated that there are now 9,200 cases of monkeypox in 63 countries around the world. WHO recommends
